StonvexLoading…
StonvexStonvexStonvexCore line items from CRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-30 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 |
|---|---|---|---|---|
Revenue | $11.13B | $41.52B | $30.32B | $20.07B |
Operating Income | $2.35B | $8.33B | $6.46B | $4.27B |
Net Income | $2.11B | $7.46B | $5.51B | $1.89B |
EPS (Diluted) | $2.42 | $7.80 | $5.73 | $3.55 |
Total Assets | $106.68B | $112.31B | $95.14B | $97.57B |
Total Liabilities | $72.44B | $53.16B | $35.12B | $36.24B |
Cash & Equivalents | $8.94B | $7.33B | $8.98B | $10.37B |
Free Cash Flow OCF − CapEx | $6.56B | $14.40B | $9.08B | $6.90B |
Shares Outstanding | 871.00M | 929.00M | 962.00M | 966.00M |